Afamelanotide Significantly Reduces DNA Damage in a Healthy Population 2023 Announcements . Corporate 15.08.2023
SCENESSE® applied under five-year Veterans Affairs contract 2023 Announcements . Corporate 26.07.2023
CLINUVEL secures IP for melanocortins to treat central nervous system disorders 2023 Announcements . Corporate 14.07.2023
CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients 2023 Announcements . Clinical . News . Regulatory 09.05.2023